MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

Search

Bausch Health Cos Inc

Avatud

SektorTervishoid

6.69 -1.47

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

6.5600000000000005

Max

6.86

Põhinäitajad

By Trading Economics

Sissetulek

53M

181M

Müük

-1.6B

912M

P/E

Sektori keskmine

7.196

89.037

Kasumimarginaal

19.846

Töötajad

20,700

EBITDA

1.6B

2.5B

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+21.5% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

18. veebr 2026

Turustatistika

By TradingEconomics

Turukapital

289M

2.6B

Eelmine avamishind

8.16

Eelmine sulgemishind

6.69

Uudiste sentiment

By Acuity

55%

45%

306 / 360 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

Bausch Health Cos Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

22. apr 2025, 13:12 UTC

Omandamised, ülevõtmised, äriostud

Bausch Health Learns Icahn Has 34% Economic Interest in Shares

Võrdlus sarnastega

Hinnamuutus

Bausch Health Cos Inc Prognoos

Hinnasiht

By TipRanks

21.5% tõus

12 kuu keskmine prognoos

Keskmine 8.25 USD  21.5%

Kõrge 10 USD

Madal 7 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Bausch Health Cos Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

4 ratings

0

Osta

4

Hoia

0

Müü

Tehniline skoor

By Trading Central

4.63 / 5.35Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

306 / 360 Pingereas Tervishoid

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Bausch Health Cos Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
help-icon Live chat